---
category: news
title: "AI Tool More Accurately Predicts Long-Term Outcomes in Prostate Cancer"
excerpt: "Click here to read more of Cancer Therapy Advisor’s conference coverage. An artificial intelligence (AI) tool is more effective than clinical prognostic markers for predicting long-term outcomes in patients with prostate cancer, according to a study ..."
publishedDateTime: 2022-02-17T23:00:00Z
originalUrl: "https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-clinical-oncology-genitourinary-asco-gu/asco-gu-2022/prostate-cancer-ai-tool-more-accurate-predicts-long-term-outcomes/"
webUrl: "https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-clinical-oncology-genitourinary-asco-gu/asco-gu-2022/prostate-cancer-ai-tool-more-accurate-predicts-long-term-outcomes/"
type: article
quality: 19
heat: -1
published: false

provider:
  name: Cancer Therapy Advisor
  domain: cancertherapyadvisor.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "Artificial intelligence-derived biomarker predicts ADT benefit in prostate cancer subset"
    excerpt: "SAN FRANCISCO — An artificial intelligence-derived digital pathology-based biomarker ... The biomarker (ArteraAI-Predict ADT) demonstrated that a majority of men treated with radiation therapy as part of a large randomized phase 3 trial did not require ..."
    publishedDateTime: 2022-02-17T22:42:00Z
    webUrl: "https://www.healio.com/news/hematology-oncology/20220217/artificial-intelligencederived-biomarker-predicts-adt-benefit-in-prostate-cancer-subset"
    type: article
    provider:
      name: Healio
      domain: healio.com
    quality: 30
    images:
      - url: "https://www.healio.com/~/media/images/fscss/i3wyanokecdncom/healio_safe_image.png"
        width: 1024
        height: 1024
        isCached: true
  - title: "First Predictive Biomarker for ADT Use in Prostate Cancer Validated"
    excerpt: "Click here to read more of Cancer Therapy Advisor’s conference coverage. A novel digital pathology-based biomarker developed using artificial intelligence (AI) can successfully guide the use of androgen deprivation therapy (ADT) in men with intermediate ..."
    publishedDateTime: 2022-02-17T23:00:00Z
    webUrl: "https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-clinical-oncology-genitourinary-asco-gu/asco-gu-2022/prostate-cancer-predictive-biomarker-adt-validation-treatment-risk/"
    type: article
    provider:
      name: Cancer Therapy Advisor
      domain: cancertherapyadvisor.com
    quality: 4

secured: "8ONYOA8Znw7DDG/z+1Z0rjTPhQR2vxwyp+OQBaIBfVBtYivHvX82RU6zGFq+JH0q6n9lPz4oCxMK6WEPzaywxFr71SYp7wtIyGqJzwzQCtF6UxPerEtKeCz1/gJn9vykh3FWrxe2bEeEhlFVkB+OhTcQxjqPOPrbUKvFxqbz4cj0A5BwGN1SSBM2Q/3bAyXtQnIckmrdqJEt5aCoY2aX/oyE9paOhMmLicWwiEfHEdRH6Oenu1qxyEzNU6rVrWsZ8KHISUA/vZf/JQpfedN9xLP+vaqxqFB9rA4aLfqexo+J/fl/+eir1BtRBOiSQJpuIr36x+dwij7e8+ffbsWOxUXmNRTsgRc7rNpTJ8jIZAk=;8QXUfHB1/Y/UEjIPyFnvjQ=="
---

